News Search

Dr. Lawrence S. Honig, Professor of Neurology at the CUIMC, comments on the significance of Food and Drug Administration approval of the Alzheimer’s disease drug, Lecanemab

Lawrence S. Honig, MD, PhD, Professor of Neurology at the CUIMC, an investigator for the study that led to the FDA’s approval of Leqembi expresses his opinions about the new Alzheimer’s Disease drug

Andrew B. Lassman, MD, Professor of Neurology & Associate Dean of Clinical Trials at Columbia University, talks about the importance of enrolling a diverse population of subjects in clinical trials

Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, and colleagues led a study that found eye drop treatment alternative to Retinal vein occlusion (RVO) disease